NALMEFENE HCL
LIVE

Serial Number

99710822

Owner

Purdue Pharma L.P.

Attorney

Fara S. Sunderji

Filing Date

Mar 18, 2026

Add to watchlist:

No watchlists yet
View on USPTO

NALMEFENE HCL Trademark

Serial Number: 99710822

NALMEFENE HCL is a trademark filed by Purdue Pharma L.P. on March 18, 2026. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently pending registration.

Owner Contact Info

Purdue Pharma L.P.

One Stamford Forum
Stamford, CT 06901

Entity Type: 13

KNOA PHARMA LLC

ONE STAMFORD FORUM
STAMFORD, CT 06901-3431

Entity Type: 16

Trademark Details

Filing Date

March 18, 2026

Registration Date

Not Registered

Goods & Services

Pharmaceuticals for use in the treatment of opioid overdose, opioid reversal, or opioid use disorders; Pharmaceuticals, namely, opioid antagonists; Syringes filled with pharmaceuticals for use in the treatment of opioid overdose, opioid reversal, or opioid use disorders; Syringes filled with opioid antagonists; Injectors filled with pharmaceuticals for use in the treatment of opioid overdose, opioid reversal, or opioid use disorders; Injectors filled with opioid antagonists; Injectable pharmaceuticals for use in the treatment of opioid overdose, opioid reversal, or opioid use disorders; Injectable pharmaceuticals, namely, opioid antagonists

Filing History

APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 6, 2026 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 5, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 5, 2026 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 5, 2026 TROA
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Aug 19, 2026 ASGN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Aug 2, 2026 GNRN
NON-FINAL ACTION E-MAILED
Aug 2, 2026 GNRT
NON-FINAL ACTION WRITTEN
Aug 2, 2026 CNRT
ASSIGNED TO EXAMINER
Jul 30, 2026 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Jul 30, 2026 MDSM
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 29, 2026 NWOS
APPLICATION FILING RECEIPT MAILED
Mar 18, 2026 MAFR
NEW APPLICATION ENTERED
Mar 18, 2026 NWAP